Zhejiang Xinguang Pharmaceutical Co., Ltd.

SZSE:300519 Stock Report

Market Cap: CN¥1.8b

Zhejiang Xinguang Pharmaceutical Balance Sheet Health

Financial Health criteria checks 6/6

Zhejiang Xinguang Pharmaceutical has a total shareholder equity of CN¥866.5M and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥944.7M and CN¥78.2M respectively. Zhejiang Xinguang Pharmaceutical's EBIT is CN¥38.2M making its interest coverage ratio -1.6. It has cash and short-term investments of CN¥735.8M.

Key information

0%

Debt to equity ratio

CN¥0

Debt

Interest coverage ratio-1.6x
CashCN¥735.84m
EquityCN¥866.54m
Total liabilitiesCN¥78.17m
Total assetsCN¥944.72m

Recent financial health updates

No updates

Recent updates

Zhejiang Xinguang Pharmaceutical (SZSE:300519) Has Announced That Its Dividend Will Be Reduced To CN¥0.40

May 26
Zhejiang Xinguang Pharmaceutical (SZSE:300519) Has Announced That Its Dividend Will Be Reduced To CN¥0.40

Calculating The Intrinsic Value Of Zhejiang Xinguang Pharmaceutical Co., Ltd. (SZSE:300519)

Apr 16
Calculating The Intrinsic Value Of Zhejiang Xinguang Pharmaceutical Co., Ltd. (SZSE:300519)

Zhejiang Xinguang Pharmaceutical Co., Ltd.'s (SZSE:300519) Low P/E No Reason For Excitement

Feb 26
Zhejiang Xinguang Pharmaceutical Co., Ltd.'s (SZSE:300519) Low P/E No Reason For Excitement

Financial Position Analysis

Short Term Liabilities: 300519's short term assets (CN¥799.9M) exceed its short term liabilities (CN¥69.3M).

Long Term Liabilities: 300519's short term assets (CN¥799.9M) exceed its long term liabilities (CN¥8.9M).


Debt to Equity History and Analysis

Debt Level: 300519 is debt free.

Reducing Debt: 300519 had no debt 5 years ago.

Debt Coverage: 300519 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 300519 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.